You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 92 No. 5, NOVEMBER 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TREATMENT OF LEUKEMIA WITH TRIETHYLENE THIOPHOSPHORAMIDE (THIO-TEPA)

Preliminary Results in Experimental and Clinical Leukemia

HARRY SHAY, M.D.; CHRIS ZARAFONETIS, M.D.; NATHAN SMITH, M.D.; IRVING WOLDOW, M.D.; DAVID C. H. SUN, M.D.

AMA Arch Intern Med. 1953;92(5):628-645.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT IS NOW nearly two hundred years since Horace Walpole coined the term serendipity, which he in part borrowed from the title of an old legend, the "Three Princes of Serendip," who, so the story goes, went forth into the world and made discoveries of things they were not in search of through "chance" or "sagacity." The results that we have to report may well be considered as gains from serendipity, for they indirectly derive from attempts started about six years ago to produce glandular gastric cancer in rats by inducing gastric ulcer and instilling methylcholanthrene daily into the stomach through a rubber catheter. No gastric cancers were produced in this manner, but instead from these experiments there developed two useful experimental tools, one, adenocarcinoma of the breast,1 and the other, four types of leukemia. These leukemias include an acute lymphatic2 and a chronic myelongenous (chloro) leukemia,3 . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

From the Samuel S. Fels Research Institute and Temple University Hospital, Temple University School of Medicine, St. Christopher's Hospital and Einstein Medical Center, Northern Division.


Footnotes

Research Fellow, Fels Research Institute (Dr. Sun).

Read before the Section on Experimental Medicine and Therapeutics at the 102nd Annual Session of the American Medical Association, New York, June 3, 1953.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.